On Thursday evening, the medtech company lowered its guidance, as the covid-19 pandemic continues to affect the number of operations being performed while also disrupting the firm's supply chain, according to an Ambu press release.
Now, Ambu expects to realize organic growth in 2021/2022 at around 17 percent compared to 17-20 percent previously forecast. It predicts that the earnings before interest an taxes will be around 10 percent, compared to 11-12 percent predicted previously.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Medical Director (diabetes and obesity) - Zealand Pharma 
Medical Scientific Liaison Dermo aesthetic, IBSA 
Senior Clinical Research Specialist - Ambu 
Development Laboratory Manager - Pharmaceutical Product Development - Orifarm 
CMC Senior Project Manager - Genmab 
Director of Communications – Evaxion Biotech 
KLIFO is looking for a talented Medical Writer (DK, SE or DE) 
A tech-savvy Project Manager Oncology (m/f/x) with a passion for communication and cross-functional collaboration - Daiichi-Sankyo 
Analytical Coordinator - Symphogen 
Associate Director, PV QA - Y-mAbs Therapeutics 
Scientific Advisor infectious disease - Vaccibody 
Project Manager, Adcendo ApS 
Global Senior Medical Advisor – Neurology Pipeline Projects, Lundbeck